Verva Pharmaceuticals -- Geelong, Australia (17th June, 2009). Verva Pharmaceuticals Ltd today announced the completion of a $2 million (AUD) financing by current investors GBS Venture Partners Ltd, Queensland Biocapital Funds Pty Ltd and Uniseed, along with new investors Westscheme Pty Ltd and MTAA Superannuation Fund (Companion Funds) Private Equity Investments Pty Ltd. The investors were issued dividend-bearing Class A preference shares with associated redemption rights and liquidation preferences.
